Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027

Go back to Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027
(NASDAQ: TVTX) Delayed: 64.74 --0 (-0%)
Previous Close $64.74    52 Week High
Open $64.74    52 Week Low
Day High $64.74    P/E N/A 
Day Low $64.74    EPS
Volume 28,307